Linezolid is a specific inhibitor of 50S ribosomal subunit formation in Staphylococcus aureus cells

Current Microbiology

Volumn 44, Issue 5, 2002, Pages 350-356

  Champney, W Scott ^a   Miller, Mindy ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; LINEZOLID; OXAZOLIDINONE DERIVATIVE; PROTEIN SUBUNIT; PROTEIN SYNTHESIS INHIBITOR; RIBOSOME PROTEIN;

ARTICLE; BIOSYNTHESIS; CHEMICAL MODEL; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; IC 50; PROTEIN SYNTHESIS; STAPHYLOCOCCUS AUREUS; 50S RIBOSOME SUBUNIT; BACTERIAL CELL; CELL COUNT; CONCENTRATION RESPONSE; NONHUMAN; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RIBOSOME SUBUNIT;

ACETAMIDES; ANTI-BACTERIAL AGENTS; INHIBITORY CONCENTRATION 50; MODELS, CHEMICAL; OXAZOLIDINONES; PROTEIN BIOSYNTHESIS; PROTEIN SUBUNITS; PROTEIN SYNTHESIS INHIBITORS; RIBOSOMAL PROTEINS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0036582340     PISSN: 03438651     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00284-001-0023-7     Document Type: Article

References (37)

1. Amabile-Cuevas CF, Cardenas-Garcia M, Ludgar M (1995) Antibiotic resistance. Am. Sci 83:320-329
2. Baquero F (1997) Gram-positive resistance: challenge for the development of new antibiotics. J Antimicrob Chemother 39:1-6
3. B resistance phenotype. J Antimicrob Chemother 40:85-90
4. Bryskier A, Agourides C, Chantot JF (1997) Ketolides: new semi-synthetic 14-membered macrolides. In: Zinner SH, Young LS, Acar JF, Neu HC (eds), Expanding indications for the new macrolides, azalides and streptogramins, Marcel Dekker, pp 39-50
5. Champney WS (1999) Macrolide antibiotic inhibition of 50S ribosomal subunit formation in bacterial cells. Recent Res Dev Antimicrob Agents Chemother 3:39-58
6. Champney WS (2001) Bacterial ribosomal subunit synthesis: a novel antibiotic target. Curr Drug Targets-Infecti Disorders 1:19-36
7. Champney WS, Burdine R (1996) 50S Ribosomal subunit synthesis and translation are equivalent targets for erythromycin inhibition in Staphylococcus aureus. Antimicrob Agents Chemother 40:1301-1303
8. Champney WS, Burdine R (1998) Azithromycin and clarithromycin inhibition of 50S ribosomal subunit formation in Staphylococcus aureus cells. Curr Microbiol 36:119-123
9. Champney WS, Tober CL (1998a) Inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by eleven different ketolide antibiotics. Curr Microbiol 37:418-425
10. Champney WS, Tober CL (1998b) A molecular investigation of the post-antibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells. Antimicrob Agents Chemother 43: 1324-1328
11. Champney WS, Tober CL (1999) Superiority of 11, 12 carbonate macrolide antibiotics as inhibitors of translation and 50S subunit formation in Staphylococcus aureus cells. Curr Microbiol 38:342-348
12. Champney WS, Tober CL (2000a) Evernimicin (SCH27899) inhibits both translation and 50S ribosomal subunit formation in Staphylococcus aureus cells. Antimicrob Agents Chemother. 44: 1413-1417
13. Champney WS, Tober CL (2000b) Specific inhibition of 50S ribosomal subunit formation in Staphylococcus aureus cells by 16-membered macrolide, lincosamide and streptogramin B antibiotics. Curr Microbiol 41:126-135
14. Champney WS, Tober CL, Burdine R (1998) A comparison of the inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by nine different macrolide antibiotics. Curr Microbiol 37:412-417
15. Champney WS, Pelt J, Tober CL (2001) TAN 1057A: a translational inhibitor of 50S ribosomal subunit activity and formation. Curr Microbiol in press
16. Clemett D, Markam A (2000) Linezolid. Drugs 59:815-827
17. Fines M, Leclercq R (2000) Activity of linezolid against Gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitors. J Antimicrob Chemother 45:797-802
18. Gold HS, Moellering RC (1996) Antimicrobial-drug resistance. N Engl J Med 335:1445-1453
19. Goldstein EJ, Citron DM, Merriam CV (1999) Linezolid activity compared to those of selected macrolides and other agents against aerobic and anerobic pathogens isolated from soft tissue bite infections in humans. Antimicrob Agents Chemother. 43:1469-1474
20. Jett BD, Hatter KL, Huycke M, Gilmore MS (1997) Simplified agar plate method for quantifying viable bacteria. BioTechniques 23:648-650
21. Jones RN, Johnson DM, Erwin ME (1996) In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones. Antimicrob Agents Chemother 40:720-726
22. Kaatz GW, Seo SM (1996) In vitro activities of oxazolidinone compounds U 100592 and U 100766 against Staphylococcus aureus and Staphylococcus epidermidis. Antimcrob Agents Chemother 40:799-801
23. Kloss P, Xiong L, Schinabarger DL, Mankin AS (1999) Resistance mutations in 23S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center. J Mol Biol 294:93-101
24. Lamb HM, Figgitt DP, Faulds D (1999) Quinupristin/dalfopristin. A review of its use in the management of serious Gram-positive infections. Drugs 58:1061-1097
25. Lin AH, Murray RW, Vidmar TJ, Marotti KR (1997) The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin. Antimicrob Agents Chemother 41:2127-2131
26. MacKenzie FM, Gould IM (1993) The post-antibiotic effect. J Antimicrob Chemother 32:519-537
27. Maranan MC, Moreira B, Boyle-Vavra S, Daum RS (1997) Antimicrobial resistance in staphylococci. Infecti Dis Clini Am 11: 813-849
28. Matassova NB, Rodnina MV, Endermann R, Kroll HP, Pleiss U, Wild H, Wintermeyer W (1999) Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors. RNA 5:939-946
29. Miller JH (1972) Experiments in molecular genetics. Cold Spring Harbor, NY:Cold Spring Harbor Laboratory
30. Murray RW, Schaadt RD, Zurenko GE, Marotti KR (1998) Ribosomes from an oxazolidinone-resistant mutant confer resistance to eperezolid in a Staphylococcus aureus cell-free translation assay. Antimicrob Agents Chemother 42:947-950
31. Rybak MJ, Cappelletty DM, Moldovan T, Aeschlimann JR, Kaatz GW (1998) Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Entercoccus faecalis and Entercoccus faecium. Antimicrob Agents Chemother 42:721-724
32. Shinabarger DL, Marotti KR, Murray RW, Lin AH, Melchior EP, Swaney SM, Dunyak DS, Demyan WF, Buysse JM (1997) Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation rates. Antimicrob Agents Chemother 41: 2132-2136
33. Swaney SM, Aoki H, Ganoza MC, Shinabarger DL (1998) The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother 42:3251-3255
34. Usary J, Champney WS (2001) Erythromycin inhibition of 50S ribosomal subunit formation in Escherichia coli cells. Mol Microbiol 40:951-962
35. Vogelmann BS, Craig WA (1985) Postantibiotic effects. J Antimicrob Chemother 15:37-46
36. Xiong L, Kloss P, Douthwaite S, Andersen NM, Swaney S, Shinabarger DL, Mankin AS (2000) Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action. J Bacteriol 182:5325-5331
37. Zurenko GE, Yagi BH, Schaadt RD, Allison JW, Kilburn JO, Glickman SE, Hutchinson DK, Barbachyn MR, Brickner SJ (1996) In vitro activities of U-100592 and U-100766, novel oxazolidione antibacterial agents. Antimicrob Agents Chemother 40:839-845